347 related articles for article (PubMed ID: 16555021)
1. Expression of prostate-specific membrane antigen in normal and malignant human tissues.
Kinoshita Y; Kuratsukuri K; Landas S; Imaida K; Rovito PM; Wang CY; Haas GP
World J Surg; 2006 Apr; 30(4):628-36. PubMed ID: 16555021
[TBL] [Abstract][Full Text] [Related]
2. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
Chang SS; Reuter VE; Heston WD; Bander NH; Grauer LS; Gaudin PB
Cancer Res; 1999 Jul; 59(13):3192-8. PubMed ID: 10397265
[TBL] [Abstract][Full Text] [Related]
3. Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues.
Chang SS; Reuter VE; Heston WD; Hutchinson B; Grauer LS; Gaudin PB
Cancer; 2000 Jan; 88(2):407-15. PubMed ID: 10640975
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific membrane antigen expression in normal and malignant human tissues.
Silver DA; Pellicer I; Fair WR; Heston WD; Cordon-Cardo C
Clin Cancer Res; 1997 Jan; 3(1):81-5. PubMed ID: 9815541
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma.
Chang SS; Reuter VE; Heston WD; Gaudin PB
Urology; 2001 Jun; 57(6):1179-83. PubMed ID: 11377343
[TBL] [Abstract][Full Text] [Related]
7. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids.
Troyer JK; Beckett ML; Wright GL
Int J Cancer; 1995 Sep; 62(5):552-8. PubMed ID: 7665226
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of PSMA, TERT and PDEF in malignant tumors of the prostate.
Situ J; Zhang H; Lu L; Li K; Hu C; Wang DJ
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3347-3352. PubMed ID: 28829509
[TBL] [Abstract][Full Text] [Related]
10. Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.
Samplaski MK; Heston W; Elson P; Magi-Galluzzi C; Hansel DE
Mod Pathol; 2011 Nov; 24(11):1521-9. PubMed ID: 21725290
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Prostate-specific Membrane Antigen (PSMA/FOLH1) Expression in a Genomic Database.
Bahler CD; Johnson MM; Davicioni E; Zhang J; Cheng L; Green MA; Koch MO
Urology; 2020 Oct; 144():117-122. PubMed ID: 32619596
[TBL] [Abstract][Full Text] [Related]
12. PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples.
Antunes AA; Reis ST; Leite KR; Real DM; Sousa-Canavez JM; Camara-Lopes LH; Dall'Oglio MF; Srougi M
Int Braz J Urol; 2013; 39(5):649-56. PubMed ID: 24267108
[TBL] [Abstract][Full Text] [Related]
13. Glycoforms of human prostate-specific membrane antigen (PSMA) in human cells and prostate tissue.
Yuan W; Liu B; Sanda M; Wei R; Benicky J; Novakova Z; Barinka C; Goldman R
Prostate; 2022 Jan; 82(1):132-144. PubMed ID: 34662441
[TBL] [Abstract][Full Text] [Related]
14. Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies.
Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Ben Rais N; Ouertani L; Nouira Y; Horchani A; Oueslati R
J Exp Clin Cancer Res; 2010 Dec; 29(1):171. PubMed ID: 21189143
[TBL] [Abstract][Full Text] [Related]
15. Re: PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples.
Wiwanitkit S
Int Braz J Urol; 2014; 40(2):285; author reply 286. PubMed ID: 24856501
[No Abstract] [Full Text] [Related]
16. Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene.
O'Keefe DS; Bacich DJ; Heston WD
Prostate; 2004 Feb; 58(2):200-10. PubMed ID: 14716746
[TBL] [Abstract][Full Text] [Related]
17. Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer.
Murphy GP; Kenny GM; Ragde H; Wolfert RL; Boynton AL; Holmes EH; Misrock SL; Bartsch G; Klocker H; Pointner J; Reissigl A; McLeod DG; Douglas T; Morgan T; Gilbaugh J
Urology; 1998 May; 51(5A Suppl):89-97. PubMed ID: 9610563
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen.
Huang X; Bennett M; Thorpe PE
Prostate; 2004 Sep; 61(1):1-11. PubMed ID: 15287089
[TBL] [Abstract][Full Text] [Related]
19. The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research.
Ristau BT; O'Keefe DS; Bacich DJ
Urol Oncol; 2014 Apr; 32(3):272-9. PubMed ID: 24321253
[TBL] [Abstract][Full Text] [Related]
20. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.
Minner S; Wittmer C; Graefen M; Salomon G; Steuber T; Haese A; Huland H; Bokemeyer C; Yekebas E; Dierlamm J; Balabanov S; Kilic E; Wilczak W; Simon R; Sauter G; Schlomm T
Prostate; 2011 Feb; 71(3):281-8. PubMed ID: 20809553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
